Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

Hermans N, Phelan J, Sorrentino R, Boysen F, Sherry NL, Miotto P, Cirillo DM, Chindelevitch L, Rodwell TC, Barilar I, Niemann S, Andres S, Mischnik A, Horan K, Bond K, Globan M, Rubinstein M, Losev Y, Clark TG, Mitarai S, Iskakova A, Slyzkyi A, Köser CU, Kremer K, Anthony R

Open source

DOI: 10.1128/spectrum.01821-26
Published: 2026 Aug 26
Container: Microbiology spectrum
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/spectrum.01821-26,
  title = {Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.},
  author = {Hermans N and Phelan J and Sorrentino R and Boysen F and Sherry NL and Miotto P and Cirillo DM and Chindelevitch L and Rodwell TC and Barilar I and Niemann S and Andres S and Mischnik A and Horan K and Bond K and Globan M and Rubinstein M and Losev Y and Clark TG and Mitarai S and Iskakova A and Slyzkyi A and Köser CU and Kremer K and Anthony R},
  year = {2026},
  journal = {Microbiology spectrum},
  doi = {10.1128/spectrum.01821-26},
  url = {https://doi.org/10.1128/spectrum.01821-26}
}

RIS

TY  - JOUR
TI  - Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.
AU  - Hermans N
AU  - Phelan J
AU  - Sorrentino R
AU  - Boysen F
AU  - Sherry NL
AU  - Miotto P
AU  - Cirillo DM
AU  - Chindelevitch L
AU  - Rodwell TC
AU  - Barilar I
AU  - Niemann S
AU  - Andres S
AU  - Mischnik A
AU  - Horan K
AU  - Bond K
AU  - Globan M
AU  - Rubinstein M
AU  - Losev Y
AU  - Clark TG
AU  - Mitarai S
AU  - Iskakova A
AU  - Slyzkyi A
AU  - Köser CU
AU  - Kremer K
AU  - Anthony R
PY  - 2026
JO  - Microbiology spectrum
DO  - 10.1128/spectrum.01821-26
UR  - https://doi.org/10.1128/spectrum.01821-26
ER  -

APA

N, H., J, P., R, S., F, B., NL, S., P, M., DM, C., L, C., TC, R., I, B., S, N., S, A., A, M., K, H., K, B., M, G., M, R., Y, L., TG, C., S, M., A, I., A, S., CU, K., K, K., & R, A. (2026). Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.. Microbiology spectrum. https://doi.org/10.1128/spectrum.01821-26

Source records

pubmed · retrieved 2026-09-25T18:13:22.621Z